Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice

被引:0
作者
Jayashri Kulkarni
Sacha Filia
Lesley Berk
Kate Filia
Seetal Dodd
Anthony de Castella
Alan JM Brnabic
Amanda J Lowry
Katarina Kelin
William Montgomery
Paul B Fitzgerald
Michael Berk
机构
[1] Central Clinical School,Monash Alfred Psychiatry Research Centre, The Alfred Hospital and Monash University
[2] The University of Melbourne,Department of Psychiatry
[3] Optum,Global Health Outcomes
[4] Eli Lilly Australia Pty Ltd,Florey Institute for Neuroscience and Mental Health
[5] Intercontinental Region,School of Medicine
[6] Eli Lilly Australia Pty Ltd,undefined
[7] Orygen Research Centre,undefined
[8] University of Melbourne,undefined
[9] Deakin University,undefined
来源
BMC Psychiatry | / 12卷
关键词
Bipolar Disorder; Olanzapine; Propensity Score; Study Entry; Mood Stabilizer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 270 条
[1]  
Berk M(2005)'Bipolar missed states': the diagnosis and clinical salience of bipolar mixed states Aust N Z J Psychiatry 39 215-221
[2]  
Dodd S(2007)Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch Gen Psychiatry 64 543-552
[3]  
Malhi GS(2005)Bipolar I and II disorders in a random and representative Australian population Aust N Z J Psychiatry 39 726-729
[4]  
Merikangas KR(2011)Changes in the prevalence of bipolar disorders between 1998 and 2008 in an Australian population Bipolar Disord 13 182-188
[5]  
Akiskal HS(2008)Update on the treatment and management of schizophrenia and bipolar disorder CNS Spectr 13 1-10
[6]  
Angst J(2003)Unmet clinical needs in bipolar disorder J Clin Psychopharmacol 23 S2-S8
[7]  
Greenberg PE(2009)Is lithium in a class of its own? A brief profile of its clinical use Aust N Z J Psychiatry 43 1096-1104
[8]  
Hirschfeld RM(2009)Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 Bipolar Disord 11 225-255
[9]  
Petukhova M(2011)Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis Lancet 378 1306-1315
[10]  
Kessler RC(1998)Mood stabilizer combinations: a review of safety and efficacy Am J Psychiatry 155 12-21